Form D Explorer

Inspect source fieldsReport a record issue

Form D — Aevum Longevity Corp.

0002076042-25-000001 · filed Jul 9, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$2,251
Reported amount sold
$2,251
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Aevum Longevity Corp.
CIK
2076042
Entity
Corporation
Jurisdiction
BRITISH COLUMBIA, CANADA
Year incorporated
2023
Address
2501 - 550 BURRARD STREET
VANCOUVER, British Columbia, Canada V6C 2B5
Phone
604-868-1669

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗